1/25
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
famotidine
pepcid
anti-acid
therapeutic class of famotidine/pepcid
histamine-2 receptor antagonist (H2RA)
pharmacologic class of famotidine/pepcid
sucralfate
carafate
gastrointestinal protectant
therapeutic class of sucralfate/carafate
omeprazole
prilosec
anti-acid
therapeutic class of omperazole/prilosec
ppi
pharmacologic class of omeprazole/prilosec
lansoprazole
prevacidan
anti-acid
therapeutic class of lansoprazole/prevacid
ppi
pharmacologic class of lansoprazole/prevacid
pantoprazole
protonix
anti-acid
therapeutic class of pantoprazole/protonix
ppi
pharmacologic class of pantoprazole/protonix
esomprazole
nexium
anti acid
therapeutic class of esomeprazole/nexium
ppi
pharmacologic class of esomeprazole/nexium
dexlansoprazole
dexilant
anti acid
therapeutic class of dexlansoprazole/dexilant
ppi
pharmacologic class of dexlansoprazole/dexilant
blocks H2 receptor on parietal cells
MOA of famotidine/pepcid
makes paste like coating in stomach
MOA of sucralfate/carafate
inhibits acid pump on parietal cells
MOA for PPIs
renal dose adjustment
major characteristic of famotidine/pepcid
inhibits absorption of other meds
major characteristic of sucralfate/carafate
rebound heartburn when stopped
major characteristic of PPIs